Adiposity: Clinical Trials

4 trials for Adiposity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Recruiting 1

Follow Adiposity: new trials by email Literature Review of Adiposity trials Research Report on Adiposity

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiometabolic Consequences of the Loss of Ovarian Function
Degarelix, Transdermal Estradiol Patch, Transdermal Placebo Patch - Menopause, Estrogen Deficiency
Phase 4RecruitingUniversity of Colorado, Denver1002024-06-012024-06-20
Kybella for the Treatment of Flank Fat (FF)
Kybella Flanks - Adiposity
Phase 4CompletedBeer, Kenneth R., M.D., PA102021-07-222022-04-01
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
Cyanocobalamin, Dulaglutide - Glucose Intolerance, Overweight and Obesity
Phase 4CompletedThe University of Texas Health Science Center, Houston232020-05-152024-12-05
Kybella With Triamcinolone
Injectable sodium deoxycholate, Injectable sodium deoxycholate with Triamcinolone acetate - Adiposity
Phase 4CompletedGoldman, Butterwick, Fitzpatrick and Groff302018-03-262019-05-09

Narrower conditions

Obesity (4)  ·  Glucose Intolerance (1)  ·  Overweight (1)  ·  Prediabetic State (1)

Broader conditions

Body Weight (4)  ·  Nutrition Disorders (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Overnutrition (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Overweight (3)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperglycemia (1)  ·  Metabolic Diseases (1)

Interventions

Deoxycholic Acid (1)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1)  ·  Triamcinolone (1)  ·  Vitamin B 12 (1)  ·  acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1)  ·  dulaglutide (1)

Sponsors

Beer, Kenneth R., M.D., PA (1)  ·  Goldman, Butterwick, Fitzpatrick and Groff (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Colorado, Denver (1)

Countries

United States (4)

Top investigators

Absalon D Gutierrez, MD (1)  ·  Kenneth Beer, M.D. (1)  ·  Kerrie Moreau, PhD (1)

NIH funding

R21DK122234 (1), U54AG062319 (1)